Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

Phase 3

2(40.0%)

Phase 2

2(40.0%)

Phase 1

1(20.0%)

5Total

Phase 3(2)

Phase 2(2)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT03158532Phase 3Completed

Prevention of Radial Artery Occlusion After Transradial Access Using Nitroglycerin

Role: lead

NCT06535620Phase 1Not Yet Recruiting

Comparison of the Effect of Red Wine With Alcohol on Flow-mediated Dilation Versus Red Wine Without Alcohol

Role: lead

NCT03015064Active Not Recruiting

Post-Myocardial Infarction Patients in Santa Catarina, Brazil - Catarina Heart Study

Role: lead

NCT02343276Phase 3Completed

Randomized Clinical Trial Comparing Transradial Catheterization With or Without Spasmolytic Drugs

Role: lead

NCT01741558Phase 2Unknown

The Effects of mETHotrexate Therapy on ST Segment Elevation MYocardial InfarctionS (TETHYS Trial)

Role: collaborator

NCT01754675Phase 2Completed

Cardiovascular Effects of a Soccer Match in Viewers With With Coronary Artery Disease

Role: lead

All 6 trials loaded